Also listed on Novartis AG, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 1, 2031 · High confidence
20-year base term ends Jul 13, 2030
Filed Sep 18, 2015 as application 14/859,126 · Granted Sep 4, 2018
Base term plus 172 days of patent term adjustment (USPTO delay)
Today
2010
2031
Clock starts
Jul 13, 2010
Jul 13, 2010
Term ends
Jan 1, 2031
Jan 1, 2031
Granted
Sep 4, 2018
Sep 4, 2018
base term
patent term adjustment
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
172
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 172 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 13, 2010, when application PCT/US2010/041850, the earliest non-provisional in its chain, was filed (this one was filed Sep 18, 2015) | Jul 13, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +172 days, USPTO patent term adjustment record | Jan 1, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 1, 2031 | High confidence |
This family
| Application PCT/US2010/041850 | PCT application no patent term | no patent term |
| US 9,139,633 | In force Jul 2030 | Jul 2030 |
| US 10,064,918 | this patent Jan 2031 | Jan 2031 |
| US 10,555,990 | In force Jul 2030 | Jul 2030 |
| US 11,241,482 | In force Jul 2030 | Jul 2030 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 7, 2019 Reel 49098, frame 150 | Jennings, Lori; Johnson, Kristen | Novartis Institute for Functional Genomics, Inc. | Assignment of Assignor's Interest |
| May 7, 2019 Reel 49098, frame 90 | Schultz, Peter | The Scripps Research Institute | Assignment of Assignor's Interest |
| May 7, 2019 Reel 49098, frame 208 | Novartis Institute for Functional Genomics, Inc. | Irm LLC | Assignment of Assignor's Interest |
| May 7, 2019 Reel 49098, frame 257 | Irm LLC; Novartis International Pharmaceutical Ltd. | Novartis International Pharmaceuticals Ltd. | Merger and Change of Name |
| May 7, 2019 Reel 49098, frame 307 | Novartis International Pharmaceutical Ltd. | Novartis AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jan 2031
Term ends Jan 1, 2031. Maintenance fees still fall due before then
Note
The 172 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
2
later US patents cite this one
That is below the median of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.